Prescription drug pricing Pharmacy Benefit Managers (PBM) and Pharmacy Policy and Reimbursement Issues Tax Reform Implementation Issues TRICARE Policy Issues including Telehealth, Value-Based Care, and T-5 Transition NDAA Implementation Policy Issues Veterans Healthcare and Policy Issues Implementation of National Defense Authorization Act for Fiscal Year 2024 Public Law No: 118-31 Medicare Advantage (MA) Policy and Reimbursement Enactment of policies in Calendar Year (CY) 2024 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies Medicare Part D Issues Medicaid Policy Issues Including Redeterminations and Dual Eligibles Pharmacy Benefit Managers (PBM) and Pharmacy Policy and Reimbursement Issues Home Health Policy and Reimbursement Issues Implementation of Inflation Reduction Act of 2022 Public Law No. 117-169 S. 3018/H.R. 3173, Improving Seniors Timely Access to Care Act (117th Congress) Prior Authorization Policy and Regulatory Issues CMS-4185-F2 Medicare Advantage Risk Adjustment Data Validation Final Rule Primary Care and Value-Based Care Policy and Reimbursement Clinical Policy Issues Including Workforce and Mental Health Contract Year 2025 Policy and Technical Changes to the Medicare Advantage Plan Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly, and Health Information Technology Standards (CMS-4205-P) Calendar Year (CY) 2024 Home Health Prospective Payment System Final Rule (CMS-1780-F) Calendar Year (CY) 2024 Medicare Physician Fee Schedule Final Rule (CMS-1784-F) Hospital Outpatient Prospective Payment System (OPPS): Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022 Final Rule (CMS 1793-F) Fiscal Year (FY) 2025 Hospice Payment Rate Update Proposed Rule (CMS-1810-P) Fiscal Year (FY) 2025 Skilled Nursing Facility Prospective Payment System Proposed Rule (CMS 1802-P) Draft Calendar Year (CY) 2025 Part D Redesign Program Instructions Calendar Year (CY) 2025 Advance Notice for the Medicare Advantage (MA) and Medicare Part D Prescription Drug Programs Medicare Prescription Payment Plan: Final Part One Guidance on Select Topics, Implementation of Section 1860D-2 of the Social Security Act for 2025, and Response to Relevant Comments Medicare Prescription Payment Plan: Draft Part Two Guidance on Select Topics, Implementation of Section 1860D-2 of the Social Security Act for 2025, and Solicitation of Comments CMS Interoperability and Prior Authorization final rule (CMS-0057-F)
PHA - Pharmacy TAX - Taxation/Internal Revenue Code DEF - Defense MMM - Medicare/Medicaid
136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 12 - White House Office 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of 12 - White House Office 25 - Defense, Dept of (DOD) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 42 - Veterans Affairs, Dept of (VA) 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 12 - White House Office
HUMANA, INC.
500 WEST MAIN STREET, LOUISVILLE, KY, 40202, US
TIFFANY HAVERLY (Rep. Adrian Smith, Dep. COS/Sr. Advr.; Comms. Dir./Sr. Advr. Rep. Kay Granger, Strat. Comms. Advr. Rep. Greg Walden, Comms. Dir. Rep. Phil Roe, Comms. Dir.; Leg/Press/Staff Asst.; Leg. Corr. Rep. David Davis, Staff Asst.) JEFFREY LUNGREN VERONICA JACKSON RACHEL MAGNUSON TIFFANY HAVERLY (Rep. Adrian Smith, Dep. COS/Sr. Advr.; Comms. Dir./Sr. Advr. Rep. Kay Granger, Strat. Comms. Advr. Rep. Greg Walden, Comms. Dir. Rep. Phil Roe, Comms. Dir.; Leg/Press/Staff Asst.; Leg. Corr. Rep. David Davis, Staff Asst.) VERONICA JACKSON JEFFREY LUNGREN RACHEL MAGNUSON TIFFANY HAVERLY (Rep. Adrian Smith, Dep. COS/Sr. Advr.; Comms. Dir./Sr. Advr. Rep. Kay Granger, Strat. Comms. Advr. Rep. Greg Walden, Comms. Dir. Rep. Phil Roe, Comms. Dir.; Leg/Press/Staff Asst.; Leg. Corr. Rep. David Davis, Staff Asst.) VERONICA JACKSON JEFFREY LUNGREN RACHEL MAGNUSON TIFFANY HAVERLY (Rep. Adrian Smith, Dep. COS/Sr. Advr.; Comms. Dir./Sr. Advr. Rep. Kay Granger, Strat. Comms. Advr. Rep. Greg Walden, Comms. Dir. Rep. Phil Roe, Comms. Dir.; Leg/Press/Staff Asst.; Leg. Corr. Rep. David Davis, Staff Asst.) VERONICA JACKSON JEFFREY LUNGREN RACHEL MAGNUSON
Rep. Adrian Smith, Dep. COS/Sr. Advr.; Comms. Dir./Sr. Advr. Rep. Kay Granger, Strat. Comms. Advr. Rep. Greg Walden, Comms. Dir. Rep. Phil Roe, Comms. Dir.; Leg/Press/Staff Asst.; Leg. Corr. Rep. David Davis, Staff Asst. Rep. Adrian Smith, Dep. COS/Sr. Advr.; Comms. Dir./Sr. Advr. Rep. Kay Granger, Strat. Comms. Advr. Rep. Greg Walden, Comms. Dir. Rep. Phil Roe, Comms. Dir.; Leg/Press/Staff Asst.; Leg. Corr. Rep. David Davis, Staff Asst. Rep. Adrian Smith, Dep. COS/Sr. Advr.; Comms. Dir./Sr. Advr. Rep. Kay Granger, Strat. Comms. Advr. Rep. Greg Walden, Comms. Dir. Rep. Phil Roe, Comms. Dir.; Leg/Press/Staff Asst.; Leg. Corr. Rep. David Davis, Staff Asst. Rep. Adrian Smith, Dep. COS/Sr. Advr.; Comms. Dir./Sr. Advr. Rep. Kay Granger, Strat. Comms. Advr. Rep. Greg Walden, Comms. Dir. Rep. Phil Roe, Comms. Dir.; Leg/Press/Staff Asst.; Leg. Corr. Rep. David Davis, Staff Asst.